Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Emma E. Page"'
Autor:
Jack Williams, Peter Vickerman, Elizabeth Smout, Emma E. Page, Khine Phyu, Mark Aldersley, Gaia Nebbia, Sam Douthwaite, Laura Hunter, Murad Ruf, Alec Miners
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background Numerous studies have shown the effectiveness of testing for hepatitis B (HBV) and hepatitis C (HCV) in emergency departments (ED), due to the elevated prevalence amongst attendees. The aim of this study was to conduct a cost-effe
Externí odkaz:
https://doaj.org/article/dbc8136f51b746049c458b84ea136a50
Autor:
Elizabeth Smout, Khine Phyu, Gareth J. Hughes, Lee Parker, Roozbeh Rezai, Amy Evans, Joscelyne McLaren, Stephen Bush, Sarah Davey, Mark A. Aldersley, Murad Ruf, Emma E. Page
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Innovative testing approaches and care pathways are required to meet HIV, hepatitis B (HBV) and hepatitis C (HCV) elimination goals. Routine testing for blood-borne viruses (BBVs) within emergency departments (EDs) is suggested by the Europe
Externí odkaz:
https://doaj.org/article/e04403594d444610a4c3cbf1446b315b
Autor:
Mathew A. Beale, Louise Thorn, Michelle J. Cole, Rachel Pitt, Hannah Charles, Michael Ewens, Patrick French, Malcolm Guiver, Emma E. Page, Erasmus Smit, Jaime H. Vera, Katy Sinka, Gwenda Hughes, Michael Marks, Helen Fifer, Nicholas R. Thomson
BackgroundSyphilis is a sexually transmitted bacterial infection caused byTreponema pallidumsubspeciespallidum, with approximately 6.3 million annual cases globally. Over the last decade, syphilis rates have risen dramatically in many high-income cou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::963cc740c5357c4b6952b66e951657f6
https://doi.org/10.1101/2022.12.02.22283031
https://doi.org/10.1101/2022.12.02.22283031
Autor:
Tetyana I. Vasylyeva, Yvonne Gilleece, Chris Davis, Daniel Bradshaw, Laura Waters, Julien Thézé, Mark Nelson, E. Thomson, Marianne Martinello, Graham S Cooke, Oliver G. Pybus, Emma E Page, Ruth Burholt, Gail V. Matthews
Publikováno v:
Journal of Viral Hepatitis
Journal of Viral Hepatitis, Wiley-Blackwell, 2020, 27 (7), pp.721-730. ⟨10.1111/jvh.13286⟩
Journal of Viral Hepatitis, Wiley-Blackwell, 2020, 27 (7), pp.721-730. ⟨10.1111/jvh.13286⟩
We sought to characterize risk factors and patterns of HCV transmission amongst men who have sex with men (MSM). MSM with recently acquired HCV (AHCV) were prospectively recruited ('clinic cohort') between January and September 2017. Clinical data an
Autor:
Malcolm Guiver, Helen Fifer, David M. Whiley, Andrey Obukhov, Ranmini Kularatne, Candela Fernández-Naval, Michelle J Cole, Eszter Balla, Maider Arando, Rachel Pitt, Deborah A Williamson, Emma E. Page, Rafil Khairulin, Anna Grankvist, Magnus Unemo, Nicholas R. Thomson, Emma L. Sweeney, Chris Kenyon, Michael Marks, Barbara J. Molini, Erasmus Smit, Muhammad Morshed, Christopher Ruis, Fruzsina Petrovay, Sandy Shokoples, Sheila A. Lukehart, Gwenda Hughes, Tania Crucitti, Dominic Rowley, Prenilla Naidu, Cornelis A. Rietmeijer, Christine Wennerås, Jaime H. Vera, Mathew A. Beale, Mel Krajden, Min-Kuang Lee, George Taiaroa, Michael Ewens
Publikováno v:
Oral presentations.
Syphilis is an important sexually transmitted infection caused by the bacterium Treponema pallidum subspecies pallidum. The last two decades have seen syphilis incidence rise in many high-income countries, yet the evolutionary and epidemiological rel
Autor:
Michael Ewens, Eszter Balla, Emma L. Sweeney, Rafil Khairulin, Maider Arando, Malcolm Guiver, Rachel Pitt, Candela Fernández-Naval, Ranmini Kularatne, Magnus Unemo, Andrey Obukhov, Barbara J. Molini, Michelle J Cole, Jaime H. Vera, Min-Kuang Lee, David M. Whiley, Anna Grankvist, Cornelis A. Rietmeijer, Chris Kenyon, Prenilla Naidu, Mel Krajden, Deborah A Williamson, Emma E. Page, Helen Fifer, Mathew A. Beale, Erasmus Smit, Christopher Ruis, Sandy Shokoples, Gwenda Hughes, Tania Crucitti, George Taiaroa, Dominic Rowley, Muhammad Morshed, Sheila A. Lukehart, Fruzsina Petrovay, Nicholas R. Thomson, Michael Marks, Christine Wennerås
Syphilis is an important sexually transmitted infection caused by the bacterium Treponema pallidum subspecies pallidum. The last two decades have seen syphilis incidence rise in many high-income countries, yet the evolutionary and epidemiological rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7c96b4d47b38832260438749c68276e
https://doi.org/10.1101/2021.03.25.21250180
https://doi.org/10.1101/2021.03.25.21250180
Autor:
Emma E. Page, Dietmar Fuchs, Panagiotis Pantelidis, Anton Pozniak, Peter Kelleher, Mark T. Nelson, Adriano Boasso, Sally-Ann Clark, Frances Gotch, Melanie Hart, Brian Gazzard, Louise Greathead, Rebecca Metcalf
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 67(3)
Background Immune activation plays a key role in the immunopathogenesis of HIV-1 infection. Microbial translocation, secondary to loss of epithelial integrity and mucosal immune deficiency, is believed to contribute to systemic immune activation. Int
Autor:
Tridgett M; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Mulet M; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Johny SP; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Ababi M; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Raghunath M; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Fustinoni C; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Galabova B; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Fernández-Díaz C; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Mikalajūnaitė I; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Tomás HA; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Kucej M; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Dunajová L; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Zgrundo Z; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Page E; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., McCall L; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Parker-Manuel R; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Payne T; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Peckett M; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Kent J; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Holland L; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Asatryan R; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Montgomery L; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Chow TL; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Beveridge R; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Salkauskaite I; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Alam MT; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Hollard D; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Dowding S; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Gabriel HB; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Branciaroli C; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Cawood R; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Valenti W; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK.; WuXi Advanced Therapies, 4701 League Island Blvd, Philadelphia, PA 19112, USA., Chang D; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK.; WuXi Advanced Therapies, 4701 League Island Blvd, Philadelphia, PA 19112, USA., Patrício MI; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK., Liu Q; OXGENE, A WuXi Advanced Therapies Company, Medawar Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, UK.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2024 Aug 08; Vol. 32 (3), pp. 101315. Date of Electronic Publication: 2024 Aug 08 (Print Publication: 2024).
Autor:
Baugh R; Department of Oncology, University of Oxford, Oxford, UK., Khalique H; Department of Oncology, University of Oxford, Oxford, UK., Page E; Department of Oncology, University of Oxford, Oxford, UK., Lei-Rossmann J; Department of Oncology, University of Oxford, Oxford, UK., Wan PK; Department of Oncology, University of Oxford, Oxford, UK., Johanssen T; Target Discovery Institute, University of Oxford Nuffield Department of Medicine, Oxford, UK., Ebner D; Target Discovery Institute, University of Oxford Nuffield Department of Medicine, Oxford, UK., Ansorge O; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK., Seymour LW; Department of Oncology, University of Oxford, Oxford, UK len.seymour@oncology.ox.ac.uk.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 May 09; Vol. 12 (5). Date of Electronic Publication: 2024 May 09.
Autor:
Bradshaw D; UK Health Security Agency, London, UK., Harrison K; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Page E; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Taha Y; Newcastle Hospitals NHS Foundation Trust, Newcastle-Upon-Tyne, UK., Killip M; UK Health Security Agency, London, UK., Parkes S; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Lloyd C; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Kokocinska M; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Davies K; UK Health Security Agency, London, UK., Beetar-King T; UK Health Security Agency, London, UK., Zambon M; UK Health Security Agency, London, UK., Kelly D; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Publikováno v:
Journal of infection prevention [J Infect Prev] 2024 Mar; Vol. 25 (1-2), pp. 38-40. Date of Electronic Publication: 2024 Jan 16.